Last reviewed · How we verify

NCT04644861: CAPACITY70

Adapted Physical Activity Centre (in The) CITY for Elders Aged 70 and Over with At Least One Long Term Illness

Completed NA Last updated 25 September 2024
What this trial tests

NA trial testing Program of adapted physical activity in Chronic Disease in 37 participants. Completed in 21 February 2023.

Timeline
14 December 2020
Primary endpoint
21 February 2023
21 February 2023

Quick facts

Lead sponsorUniversity Hospital, Toulouse
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposesupportive care
Enrollment37
Start date14 December 2020
Primary completion21 February 2023
Estimated completion21 February 2023
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Toulouse

Who can join

70 and older, any sex, with Chronic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Elders aged 70 and over, living in Toulouse, with a chronic disease identified by the French social insurance as an Affection Longue Durée will be eligible to a 4 months physical activity program in a primary health center. This program will be proposed by their general practitioner. The aim of the study is to establish the feasibility of such program conduced exclusively in primary care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Program of adapted physical activity

Trials testing the same drug.

Other recruiting trials for Chronic Disease

Currently open trials in the same condition.

Other University Hospital, Toulouse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04644861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing